「浜松中納言物語」の転生--日本と唐との「とりかへばや物語」 (物語・日記文学にみる信仰 ) -- (物語文学にみる信仰の諸相)

Our data support a pivotal role for ZFP64 in GC progression by simultaneously promoting cellular chemotherapy resistance and tumor immunosuppression. Treatment with the combination of nab-paclitaxel and a GAL-1 inhibitor might benefit a subgroup of GC patients.